Globus Medical, Inc. (GMED) Institutional Ownership & Insider Trading

596 institutions reported holding Globus Medical, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 14 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

GMEDGlobus Medical, Inc.Follow GMED — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 10.9B
P/E TTM: 20.9
Dividend yield: —
52-week: —
Next earnings: 5 Nov, in 12 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

596 institutions held 88.9% of the shares. Across filers that reported both quarters, shares held changed +8.0%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	596	119	+8.0%	231	60	155	72
Mar 26	599	109	-1.8%	205	83	164	41
Dec 25	554	112	-3.2%	141	97	204	36
Sep 25	480	119	+6.0%	152	57	146	54
Jun 25	477	114	+3.3%	177	57	132	77
Mar 25	503	108	+1.3%	178	76	119	58
Dec 24	491	109	-1.7%	145	75	130	34
Sep 24	439	106	-5.2%	120	43	153	38

Globus Medical, Inc. — questions

Who owns Globus Medical, Inc. stock?: 596 institutions reported Globus Medical, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.1%), Jupiter Topco LLC (6.1%), VANGUARD CAPITAL MANAGEMENT LLC (3.8%).
Are Globus Medical, Inc. insiders buying or selling?: 14 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Globus Medical, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.